For LFC, significant reductions were observed in individuals with MAFLD (Class IV
Gradual reduction gives your body time to adjust
GHK (endogenous glycyl-L-histidyl-L-lysine) GHK-Cu (Copper Peptide) References: 1
The product mentioned in this article are not intended to diagnose, treat, cure, or prevent any disease
These typically improve over time as your body adjusts: Nausea Vomiting Diarrhea Constipation Stomach pain Decreased appetite Serious but Rare Side Effects These occur in less than 1% of patients but require immediate medical attention: Pancreatitis (pancreas inflammation) Gallbladder problems Kidney problems Severe allergic reactions Changes in vision Low blood sugar Severe stomach problems Cancer, whether thyroid or pancreatic, does not appear to be a significant risk based on current human research
van der Heide F, Dijkstra G, Porte RJ, Kleibeuker JH, Haagsma EB